Concepedia

Publication | Open Access

Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia

DOIFull Paper Access

329

Citations

35

References

2010

Year

Paul W. Ladenson, Jens D. Kristensen, E. Chester Ridgway, Anders Olsson, Bo Carlsson, Irwin Klein, John D. Baxter, Bo Angelin
New England Journal of Medicine

Abstract

In this 12-week trial, the thyroid hormone analogue eprotirome was associated with decreases in levels of atherogenic lipoproteins in patients receiving treatment with statins. (ClinicalTrials.gov number, NCT00593047.)

References

YearCitations

Page 1